EVOMMUNE INC

HQ - Palo Alto

Summary

Evommune is a clinical-stage biotechnology company discovering and developing new ways to treat immune-mediated inflammatory diseases.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 89 M

Avg. Deal Size£ 89 M

Market Context

Senior Management